HMI Obligations. On or before May 31st and December 30th of each Calendar Year in which HMI conducts any Commercialization activities for any In-Vivo [***] Product in the U.S., HMI will provide to the JSC for its review and discussion a summary of the material Commercialization activities it has, or its Affiliates have, performed since the preceding report, and the future activities it expects to initiate with respect to any In-Vivo [***] Product in the U.S. for the following [***].
Appears in 3 contracts
Samples: Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.)
HMI Obligations. On or before May 31st and December 30th of each Calendar Year in which HMI conducts any Commercialization activities for any In-Vivo [***] SCD Product in the U.S., HMI will provide to the JSC for its review and discussion a summary of the material Commercialization activities it has, or its Affiliates have, performed since the preceding report, and the future activities it expects to initiate with respect to any In-Vivo [***] SCD Product in the U.S. for the following [***].
Appears in 1 contract
Samples: Collaboration and License Agreement (Homology Medicines, Inc.)